Newest Topics

• The Future of Health Care – Join Team Medicine at Virginia Mason Medical Center by gavin
  1 hour, 7 minutes ago
• Hepatobiliary Cancer Risk in Patients With Inflammatory Bowel Disease: A Scandin by gavin
  1 day ago
• Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic revi by gavin
  1 day ago
• Percutaneous biliary stent with intraluminal brachytherapy versus palliative sur by gavin
  1 day ago
• The efficacy and safety of apatinib treatment for patients with advanced or recu by gavin
  1 day, 19 hours ago
• Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage fai by gavin
  1 day, 19 hours ago
• Efficacy and safety of EUS-guided hepaticoesophagostomy (EUS-HES) for malignant by gavin
  1 day, 19 hours ago
• Total upper transversal hepatectomy with outflow reconstruction for advanced mas by gavin
  1 day, 19 hours ago
• Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Pat by gavin
  1 day, 19 hours ago
• Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholan by gavin
  2 days, 18 hours ago
• Intrahepatic Cholangiocarcinoma: State of the Art of FGFR Inhibitors by gavin
  2 days, 18 hours ago
• Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data o by gavin
  4 days, 1 hour ago
• Systematic review of perioperative and oncologic outcomes of minimally-invasive by gavin
  4 days, 1 hour ago
• Impact of changes in the topographic classification of Klatskin tumor on inciden by gavin
  4 days, 1 hour ago
• Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholan by gavin
  4 days, 1 hour ago
• Milind M. Javle, ASCO GI 2021 – Results from a Phase II Study of Infigratinib by gavin
  4 days, 1 hour ago